常山药业(300255) - 2023 Q1 - 季度财报

Financial Performance - Net profit for the period was 558,681.84 CNY, a significant decline from 28,851,938.26 CNY in the previous period, indicating a drop of approximately 98.1%[1] - Basic and diluted earnings per share were both 0.0049 CNY, down from 0.0317 CNY in the previous period, a decrease of about 84.5%[4] - Total comprehensive income attributable to the parent company was 3,861,127.43 CNY, compared to 27,986,439.91 CNY in the previous period, a decrease of about 86.1%[4] - Operating profit for the period was 5,752,668.19 CNY, down from 33,283,613.23 CNY, a decrease of approximately 82.7%[1] - The total profit for the period was 5,744,169.24 CNY, significantly lower than 33,232,129.93 CNY in the previous period, indicating a decline of about 82.7%[1] - Net profit attributable to shareholders of the listed company was ¥4,541,481.07, down 84.68% from ¥29,651,405.14 year-on-year[39] - The net profit after deducting non-recurring gains and losses was -¥5,467,837.78, a decline of 120.01% compared to ¥27,324,880.94 in the previous year[39] - Net profit attributable to the parent company decreased by 84.68% year-on-year, mainly due to reduced sales revenue and increased operating costs[58] Revenue and Costs - Total operating costs for the period were 507,965,611.18 CNY, a decrease from 542,640,735.36 CNY in the previous period, representing a reduction of approximately 6.35%[1] - Cash received from sales of goods and services was 516,943,367.04 CNY, down from 567,261,182.52 CNY, a decline of approximately 8.8%[5] - Total operating revenue for the first quarter was ¥501,924,319.12, a decrease of 12.58% compared to ¥574,179,074.10 in the same period last year[39] - The company's operating revenue decreased by 12.58% year-on-year, primarily due to a decline in the price of heparin raw materials and a drop in sales volume of low molecular weight heparin[58] - Sales expenses decreased by 34.42% compared to the same period last year, mainly due to a decrease in sales revenue[45] Cash Flow - The net cash flow from operating activities was -99,744,873.23, an improvement from -158,674,887.67 in the previous period, indicating a 37% reduction in cash outflow[8] - Cash flow from operating activities increased by 37.14% year-on-year, primarily due to a decrease in cash paid for purchasing goods and receiving services[59] - Cash flow from investing activities decreased by 32.88% year-on-year, mainly due to reduced cash payments for the purchase of fixed assets, intangible assets, and other long-term assets[60] - Cash flow from financing activities decreased by 104.61% year-on-year, primarily due to increased cash payments for debt repayment and decreased cash received from borrowings[60] Assets and Liabilities - The total assets decreased to 5,988,652,588.93 from 6,035,803,472.83, reflecting a decline of approximately 0.78%[13] - Current assets totaled 3,768,013,582.66, down from 3,897,553,391.47, indicating a decrease of about 3.32%[13] - Inventory increased slightly to 2,457,407,774.07 from 2,431,477,436.45, showing a growth of approximately 1.06%[13] - The company's long-term assets increased to 2,220,639,006.27 from 2,138,250,081.36, representing a growth of about 3.84%[13] - The short-term borrowings rose to 1,034,922,546.84 from 971,316,007.39, an increase of approximately 6.5%[13] - Total cash inflow from financing activities was 256,504,238.08, down 42% from 439,130,477.50 in the previous period[8] - The total cash outflow from financing activities was 273,066,875.93, significantly higher than 79,967,821.89 in the previous period, resulting in a net cash flow from financing activities of -16,562,637.85[8] Other Financial Metrics - The company reported a net loss from credit impairment of 1,598,914.09 CNY, contrasting with a gain of 1,408,421.45 CNY in the previous period[1] - Other comprehensive income after tax was -680,353.64 CNY, compared to -1,664,965.23 CNY in the previous period, showing an improvement[4] - Accounts receivable financing increased by 55.40% compared to the beginning of the period, mainly due to an increase in AAA-rated bills[30] - Other income increased by 221.52% year-on-year, primarily due to an increase in government subsidies received during the period[33] - Minority interests decreased by 99.02% compared to the beginning of the period, mainly due to the net loss of the controlling subsidiary during the period[32] - Minority interest loss decreased by 398.18% year-on-year, primarily due to a decrease in net profit of the controlling subsidiary[46] - Other current assets increased by 78.14% compared to the beginning of the period, mainly due to an increase in deductible input tax[43] - Accounts receivable decreased by 86.03% compared to the beginning of the period, mainly due to a reduction in non-AAA rated notes[42] - Accounts payable decreased by 72.85% compared to the beginning of the period, primarily due to a reduction in note settlement business[44]